Company Data

Lyell Immunopharma Inc.

Ticker
LYEL
Current Price
$0.7007 6.17%
Market Cap
$195.6M
Price Target
Refer to Report
Volume
1.1M
52wk Range
$0.5092 - $3.2556
Advanced Market Data

Overview

Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy